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Recombination between coinfecting viruses had not been documented previously for a nonsegmented neg-
ative-strand RNA virus (mononegavirus). We investigated the potential of intermolecular recombination by
respiratory syncytial virus (RSV) by coinfecting HEp-2 cells with two recombinant RSV (rRSV) mutants
lacking either the G gene (G/HEK) or the NS1 and NS2 genes (NS1/2). These viruses replicate inefficiently
and form pinpoint plaques in HEp-2 cells. Therefore, potential recombined viruses with a growth and/or plaque
formation advantage should easily be identified and differentiated from the two parental viruses. Further
identification of potential recombinants was aided by the inclusion of point mutation markers in the F and L
genes of G/HEK and the design of reverse transcription-PCR (RT-PCR) primers capable of detecting these
markers. Independent coinfections and control single infections by these two rRSV mutants were performed.
In one of six coinfections, an RSV variant was identified that produced plaques slightly larger than those of
wild-type RSV in HEp-2 cells. RT-PCR and sequencing provided evidence that this variant was a recombined
RSV (rec-RSV). The rec-RSV appeared to have been generated by a polymerase jump from the G/HEK
genome to that of NS1/2 and back again in the vicinity of the SH-G-F genes. This apparently involved
nonhomologous and homologous recombination events, respectively. The recombined genome was identical to
that of the G/HEK mutant except that all but the first 12 nucleotides of the SH gene were deleted and replaced
by an insert consisting of the last 91 nucleotides of the G gene and its downstream intergenic region. This insert
could have come only from the coinfecting NS1/2 virus. This resulted in the formation of a short chimeric
SH:G gene. Northern and Western blot analysis confirmed that the rec-RSV did not express the normal SH and
G mRNAs and proteins but did express the aberrant SH:G mRNA. This provides an experimental demon-
stration of intermolecular recombination yielding a viable, helper-independent mononegavirus. However, the
isolation of only a single rec-RSV under these optimized conditions supports the idea that RSV recombination
is rare indeed.
RNA viruses maintain extensive genetic variability through
which rapid evolution can occur. For example, this variability
allows viruses to mitigate antiviral immune responses and to
adapt to new hosts. RNA viruses generate this genetic diversity
in a number of ways. The RNA-dependent RNA polymerase
of RNA viruses is relatively error prone, by some estimates
misincorporating once every 104 to 105 nucleotides (nt) (7).
The resulting swarm of mutant genomes is referred to as a
quasispecies and is thought to allow rapid adaptation of the
virus to changes in its environment. Another method of main-
taining genetic diversity is by nucleic acid exchange between
genotypically different strains or variants during coinfection of
the same host cell. The progeny genome formed as a result of
this exchange contains elements of the two or more parental
genomes. For segmented RNA viruses such as influenza virus
and rotaviruses, the exchange of genetic material most com-
monly occurs by reassortment, which involves the exchange of
entire gene segments, resulting in progeny viruses containing
segments from the parental viruses (5, 12, 24). Of course,
reassortment does not occur for nonsegmented genomes.
Another means of exchanging genetic information is by re-
combination, which involves the generation of chimeric mole-
cules containing segments derived from more than one paren-
tal molecule. For RNA viruses, most (and possibly all)
recombination events occur during RNA replication when the
polymerase switches from one template (the donor) to another
(the acceptor). This forms a chimeric progeny molecule con-
taining elements derived from both parental templates (16,
26). Recombination is termed homologous if it involves donor
and acceptor templates that share significant sequence relat-
edness, where base pairing likely guides the polymerase from
one template to the next (11, 16). Homologous recombination
can be “imprecise,” where the junction contains evidence of an
insertion, deletion, or other mutation, or “precise,” where
there is no evidence of such aberrations and the junction seems
exact and clean. Recombination is termed nonhomologous if
the donor and acceptor templates do not share significant
sequence relatedness and hence base pairing apparently is not
involved in the template switch.
Recombination is common for positive-sense RNA viruses
such as picornaviruses (6), togaviruses (8), flaviviruses (9),
retroviruses (13), and coronaviruses (11). Recombination also
has been identified for influenza A virus (14) and Tula hanta-
virus (18), as examples of segmented negative-sense RNA vi-
ruses. However, recombination yielding viable progeny had not
previously been documented experimentally for a nonsegmented
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negative-strand RNA virus (mononegavirus). Recombination
leading to large deletions and the generation of defective in-
terfering particles is very common for mononegaviruses, but
these particles are not viable alone, likely do not represent an
important reservoir for maintaining genetic diversity, and are
not considered further here. In this study, we have examined
the potential for intermolecular recombination during mixed
infection in vitro by the mononegavirus human respiratory
syncytial virus (RSV).
RSV is the prototype member of the genus Pneumovirus, of
the family Paramyxovirus and the order Mononegavirales. The
RSV strain A2 genome is a single negative-sense RNA of
15,222 nt (or 15,223 nt for the cDNA-derived version used
here) that encodes 10 major subgenomic mRNAs and 11 viral
proteins (Fig. 1). The minimum unit for RNA replication is
composed of the viral genome encapsidated by the nucleocap-
sid N protein and associated with the phosphoprotein P and
large polymerase subunit L, which together comprise the RSV
replicase. Transcription requires in addition the M2-1 protein
encoded by the upstream open reading frame of the M2
mRNA. The encapsidated genome serves as a template for
transcription, in which the viral genes are copied into mRNAs,
and for RNA replication, in which an exact positive-sense copy
of the genome, or antigenome, is synthesized and encapsidated
and serves in turn as the template for the synthesis of progeny
genome.
There were previously generated recombinant RSVs
(rRSVs) that lack both of the nonstructural proteins NS1 and
NS2 (NS1/2) or lack the attachment protein G (G/HEK)
(22). (Note that the term “recombinant” in regard to rRSV
refers to cDNA-derived virus, whereas the product of RNA
recombination during mixed infection will be designated “re-
combined” RSV [rec-RSV].) Both of these rRSVs replicate
similarly to wild-type (wt) rRSV (rA2) in Vero cells, whereas in
HEp-2 cells they replicate much less efficiently and form small
plaques. The growth restriction of these two viruses provided
the possibility for recombination between the two genomes to
generate chimeric progeny with improved growth, which would
then be readily recovered and identified from the background
of the two poorly growing parents. Indeed, this strategy pro-
vided identification of a chimeric rec-RSV generated by re-
combination between the two parents. To our knowledge, this
study represents the first report of intermolecular recombina-
tion by a mononegavirus in an experimental setting.
MATERIALS AND METHODS
Construction of the G/HEK and NS1/2 RSV mutants. The construction of
G/HEK has been described previously (22). Deletion of the G gene resulted in
an SH-F intergenic region containing the 31 upstream nt from the SH-G inter-
genic region fused to the 38 downstream nt from the G-F intergenic region. In
addition, this virus differs from its wt recombinant parent by the presence of six
translationally silent restriction sites introduced into the L gene, collectively
called the “restriction sites” (SITES) mutations. Specifically, these introduced
sites are Bsu36I (nt position 9399), SnaBI (nt 11848), PmeI (nt 13342), RsrII (nt
14083), BstEII (nt 14318), and SnaBI (nt 14477) (25). There are also two amino
acid changes, Lys-68-Glu and Gln-101-Pro, which were introduced in the F gene
together with adjacent restriction site markers and are called the HEK muta-
tions. These amino acid assignments match those found in a wt isolate of RSV
that was used to derive a series of vaccine candidates and do not appreciably
affect virus replication in vitro (25). To construct NS1/2, the D51 plasmid
containing the 5 (leader complement) end of the antigenome through the SH
gene end signal (21) was used as a template for PCR mutagenesis with Vent
DNA polymerase (New England Biolabs) by the method of Byrappa et al. (3).
This method involves the introduction of a mutation into an intact plasmid by
PCR with two oligonucleotides that prime in opposite directions and produce a
mutagenized linear plasmid, which is then self ligated and cloned. The 5-
phosphorylated primers used were as follows: forward primer, 5-GCT CTT
AGC AAA GTC AAG TTG AAT G-3 (nt 1144 to 1168); reverse primer,
5-CAT CTC TAA CCA AGG GAG TTA AAT TTA AGT GG-3 (nt 101 to 70).
The reverse primer contains the complement of the initiating methionine codon
of NS1 (underlined) as well as the adjoining sequence in the NS1 untranslated
region. The forward primer starts with the second codon of the N open reading
frame, thus joining the NS1 untranslated region with the N open reading frame
and resulting in deletion of both NS1 and NS2. The resulting PCR products were
isolated by agarose gel electrophoresis, self ligated, and transformed into DH10B
competent cells (Life Technologies). Structures were confirmed by restriction
digestion, the structure of the AatII-AvrII fragment of D51NS1/2 was confirmed
by sequencing, and the fragment was then inserted into the same window of the
full-length antigenome clone (D53) (4). The encoded rRSV lacking both NS1
and NS2 (NS1/2) was recovered essentially as described previously (4, 20). The
G/HEK and NS1/2 viruses were propagated in Vero cells, and viral titers were
determined by plaque assay under methylcellulose on Vero cells with viral
FIG. 1. Gene maps of the two rRSV mutants, G/HEK and NS1/2, used for coinfection of HEp-2 cells. Genes are identified on top by the
proteins which they encode: NS1 and NS2, nonstructural proteins 1 and 2; N, nucleocapsid protein; P, phosphoprotein; M, matrix protein; SH,
small hydrophobic protein; G, attachment protein; F, fusion protein; M2-1, transcription antitermination factor; M2-2, RNA synthesis factor (M2-1
and M2-2 are encoded by two overlapping open reading frames in the same M2 mRNA); L, large polymerase protein. HEK and SITES are point
mutations in the F and L genes, respectively, that are unique to the G/HEK mutant (see Materials and Methods). Dashed boxes indicate the gene
deletions of each rRSV mutant. The SH-F junction in G/HEK contained the upstream 31 nt of the original SH-G junction fused to the
downstream 38 nt of the original G-F junction (numbers in parentheses). In NS1/2, the ATG of the N open reading frame was fused to the
upstream nontranslated region of the NS1 gene. The placement of primers (A, B, C, D, E-HEK, E-wt, 14065, and 14535), used to differentiate the
mutant constructs by RT-PCR (Table 1 and Materials and Methods), is indicated by arrows.
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plaques being visualized by immunostaining with murine anti-F monoclonal
antibodies followed by horseradish peroxidase-coupled anti-mouse immunoglob-
ulin G antibodies and 4CN substrate (Kierkegaard & Perry Laboratories) as
described previously (15).
Coinfection in HEp-2 cells. Monolayers of HEp-2 cells at approximately 80%
confluence in T-25 flasks were inoculated with either NS1/2, G/HEK, or both
at a multiplicity of infection (MOI) of 2 PFU/cell for each virus. Six independent
coinfections and duplicate single-virus infections were established. Virus was
allowed to adsorb for 3 h at 37°C, after which the viral suspensions were replaced
with 4 ml of Opti-MEM containing 4% fetal bovine serum (FBS). The 4-ml
supernatant was harvested from each flask and replaced with fresh medium every
24 h for 7 days. The supernatants were clarified by centrifugation, snap-frozen on
dry ice, and stored at 70°C for plaque analysis. Aliquots (600 l) of each viral
supernatant collected were analyzed by plaque assay as described above in both
HEp-2 and Vero cells in six-well plates to assess plaque size and morphology.
Viral RNA was extracted from a portion (400 l) of each supernatant collected
on day 4 and analyzed by reverse transcription-PCR (RT-PCR) with discrimi-
natory primers (see below) to confirm the growth of the parental mutants in each
coinfection and single infection.
Plaque purification and growth of rec-RSV. Large wt plaques were observed in
HEp-2 cells infected with supernatants collected from days 4 to 7 of coinfection
1. Individual viral plaques were isolated as follows: medium supernatants were
adsorbed undiluted onto HEp-2 cell monolayers in six-well plates. The cells were
incubated at 37°C for 2 h. The inocula were replaced with 3 ml of 0.8% agar
(SeaKem) in modified L15 medium (Biowhittaker). The cells were incubated at
37°C for 6 days, until large plaques were seen in the cells infected with the
coinfection 1 supernatant. The agar-medium was then overlaid with 1.5 ml of
0.8% agar-medium containing 5% neutral red and incubated for an additional
24 h. Seven large plaques were picked from coinfection 1 and transferred to 2 ml
of Opti-MEM containing 1 SPG (0.218 M sucrose, 3.8 mM KH2PO4, 7.2 mM
K2HPO4, 5.4 mM sodium glutamate). One milliliter was used to infect a fresh
monolayer of HEp-2 cells, which was overlaid with agar-medium and treated in
the same manner for plaque purification. The remaining 1 ml was snap-frozen
and stored at 70°C. As a control, pinpoint plaques from coinfections 2 and 3
were picked and processed in parallel.
In this way, plaques were picked and passaged through HEp-2 cells three
times. After the third round of purification, the virus from the agar-medium plug
suspended in Opti-MEM–SPG was used to infect monolayers of HEp-2 cells to
make small virus stocks. The rec-RSV isolates were designated rec-RSV 1-1 to
1-7. rec-RSV 1-1 and 1-2 were amplified further in Vero cells to prepare virus
stocks that were used for the experiments shown in the figures.
Viral RNA extraction, RT-PCR, and sequencing. Viral RNA was extracted
from the supernatant with the QIAamp viral RNA minikit (Qiagen). The RNA
was used as a template for reverse transcription with Superscript II and random
hexamers (Invitrogen). PCR was performed using specific forward (positive-
sense) and reverse (negative-sense) primers listed below and the Advantage
cDNA polymerase mix (Clontech catalog no. 8417-1). The numbers in paren-
theses following each primer indicate its position in the complete 15,2223-nt
sequence of wt rRSV.
The following set of primers was used to distinguish between the two parental
viruses based on the presence or absence of the NS1 and NS2 genes, the G gene,
and the HEK markers in the F gene (Fig. 1 and Table 1): A (forward), 5
GAAAAAATGCGTACAACAAACTTGC 3 (nt 5 to 29); B (reverse), 5 TTA
TGGTGTCTTCTCTTCCTAACC 3 (nt 1381 to 1358); C (forward), 5 ACAA
ATTGGAAGCACACAGC 3 (nt 3979 to 3998); D (reverse), 5 TACCAACC
AGTTCTCAGAGC 3 (nt 5819 to 5800); E-wt (reverse), 5 TTGTTGCTTGT
GTGCTTTGC 3 (nt 5971 to 5952); E-HEK (reverse), 5 TTGTTGCTGGAG
TACTTTGC 3 (nt 5971 to 5952). Primer pairs A-B and C-D distinguished
between the presence and absence of the NS1 and NS2 genes or the G gene,
respectively, based on the size of the RT-PCR product (Fig. 1; Table 1). Primer
pairs C–E-wt and C–E-HEK detected the presence or absence, respectively, of
three nucleotide substitutions at positions 5963, 5966, and 5968 that result in the
HEK point mutation Gln-101-Pro in F and the insertion of a nearby marker
restriction site (Fig. 1; Table 1) (25). PCR was performed by 25 cycles of
denaturation (88°C for 30 s), annealing (62°C for 30 s), and extension (68 or 72°C
for 3 min), followed by a final 3-min extension at 68 or 72°C.
To determine the presence of the SITES mutations in the L gene, genomic
RNA was subjected to RT-PCR with the random hexamer-derived cDNA de-
scribed above and the following two primers: 14065 forward, 5 GTATAGCAT
TCATAGGTGAAGGAGC 3 (nt 14041 to 14065); 14535 reverse, 5 ATTAA
ATACTGGGAATATATTCGCAGG 3 (nt 14561 to 14535).
These two oligonucleotides prime on both the wt and SITES version of the L
gene, yielding a 521-bp product that contains the positions of three of the six
SITES mutations: this uncloned cDNA was then analyzed by sequencing with the
Applied Biosystems Big Dye system (Perkin-Elmer). Additional primer pairs
used to generate RT-PCR products for nucleotide sequencing are described in
the Results.
In vitro growth analysis. HEp-2 and Vero cell monolayers in six-well plates
were infected in triplicate with either rA2, G/HEK, NS1/2, rec-RSV 1-1, or
rec-RSV 1-2 at an MOI of 0.01. Live virus was diluted in Opti-MEM–2% FBS.
After 3 h of adsorption at 37°C, the cells were washed three times with Opti-
MEM and then 2 ml of Opti-MEM with 2% FBS was added. The entire 2-ml
supernatant was removed and replaced with fresh medium every 24 h for 7 days.
Supernatants were clarified by centrifugation, snap-frozen, and stored at 70°C
for titration. Viral titers were determined by plaque assay in Vero cells with
methylcellulose overlay and immunostaining (15).
Northern blot analysis. Confluent Vero cells in six-well plates were infected
with either rA2, G/HEK, NS1/2, rec-RSV 1-1, or rec-RSV 1-2 at an MOI of
3 or were left uninfected. Cells were harvested 24 h later, and half of each cell
preparation was used for Northern blot analysis, while the other half was used for
Western blot analysis (see below). Total RNA was extracted using Trizol-LS
reagent (Invitrogen) and the RNeasy minikit (Qiagen). RNA was electropho-
resed through a 1% agarose gel containing formaldehyde, transferred to a ni-
trocellulose membrane (Optitran, 0.2-m pore size; Schleicher & Schuell), and
hybridized with 32P-labeled double-stranded DNA (dsDNA) probes specific for
G, SH, P, or N mRNA.
Western blot analysis. Cell pellets were disrupted with 2 sample buffer (100
mM Tris-Cl [pH 6.8], 4% sodium dodecyl sulfate, 20% glycerol, 0.2% bromo-
phenol blue, 200 mM dithiothreitol) and centrifuged through Qiashredders (Qia-
gen). Five microliters (approximately 7.5  105 cell equivalents) of each sample
was electrophoresed through sodium dodecyl sulfate–4 to 20% polyacrylamide
gels (Novex) and transferred to a nitrocellulose membrane. Membranes were
incubated with rabbit polyclonal antisera to purified RSV or a peptide repre-
senting amino acids 186 to 201 of the RSV G protein or amino acids 53 to 64 of
the RSV SH protein. Bound antibodies were visualized by incubation with
horseradish peroxidase-coupled goat anti-rabbit immunoglobulin G antibodies
and chemiluminescence (Amersham).
RESULTS
Strategy for identifying and isolating potential rec-RSV. In-
termolecular recombination during coinfection had not been
documented previously for a mononegavirus, suggesting that it
is at best a rare event. To facilitate the detection of possible
rare recombinants in an experimental setting, we chose to
TABLE 1. Primer pairs used to differentiate between the G/HEK
and NS1/2 viruses based on product size and the presence or
absence of HEK point mutations in the F gene
Forward
primera Reverse primer
a Virus Product size
b
(bp)
A B wt rA2 1,327
G/HEK 1,327
NS1/2 273
C D wt rA2 1,801
G/HEK 852
NS1/2 1,801
C E-wt wt rA2 1,954
G/HEK None
NS1/2 1,954
C E-HEK wt rA2/HEK 1,963
G/HEK 1,014
NS1/2 None
14065 14535 All above 521
a See Materials and Methods for exact sequence positions and Fig. 1 for
general location in the RSV gene map.
b Primer pairs A-B and C-D differentiate between G/HEK and NS1/2 based
on product size. Primer pairs C–E-wt and C–E-HEK prime only on wt F se-
quence (found in NS1/2) and HEK F sequence (found in G/HEK), respec-
tively. Primer pair 14065-14535 primes on both wt L sequence (found in NS1/2)
and SITES L sequence (found in G/HEK), which are then differentiated by
nucleotide sequencing.
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“cross” two RSV gene deletion mutants, namely, NS1/2,
which lacks the NS1 and NS2 genes, and G/HEK, which lacks
the G gene. These viruses replicate well in Vero cells, whereas
in HEp-2 cells they replicate inefficiently and form pinpoint
plaques. The NS1 and NS2 genes are the first two genes in the
gene order while the G gene is the seventh gene (Fig. 1): the
rationale was that recombination in the intervening region
might restore the full set of genes and produce a rec-RSV with
improved replication efficiency that could be readily recovered
and identified from the background of debilitated parental
deletion viruses. Another consideration in this strategy was
that the NS1, NS2, SH, and G genes, being nonessential for
RSV replication in vitro, provided regions where nucleotide
insertions or deletions that might arise due to imprecise re-
combination might be tolerated. In addition, the G/HEK
virus had been engineered to contain point mutations resulting
in two amino acid substitutions in the F gene (called the HEK
mutations), as well as translationally silent nucleotide substi-
tutions in the L gene that resulted in the insertion of six
restriction site markers (called the SITES mutations). The
presence of these markers would discriminate between the two
parental viruses with regard to the downstream F and L genes.
Apart from these differences, the backbones of the G/HEK
and NS1/2 viruses were identical. Thus, we infected six inde-
pendent flasks of HEp-2 cells with the two viruses together,
each at an input MOI of 2 PFU per cell, and harvested super-
natants from infected cells every 24 h for 7 days. As controls,
HEp-2 cells were infected at the same MOI with each of the
parental viruses separately. We then subjected the superna-
tants to plaque analysis to screen for potential recombined
viruses.
Plaque formation by mutant rRSVs. As expected, the
NS1/2 and G/HEK single infections yielded viral superna-
tants that generated pinpoint plaques on HEp-2 cells and
larger, more distinct plaques on Vero cells, as is characteristic
of these deletion viruses (Fig. 2 and 3). In addition, extensive
plaque analysis did not reveal any evidence of large-plaque
variants in the G/HEK and NS1/2 virus stocks used for the
infections (data not shown). Similarly, only pinpoint plaques
were observed in HEp-2 cells infected by supernatants from
five of the six coinfections (data not shown). However, analysis
of supernatants collected on days 4 to 7 from coinfection 1
revealed, against the background of pinpoint plaques, a small
number of large plaques that were somewhat greater in size
than those of wt rRSV strain A2 (wt rA2) (Fig. 2b). When
HEp-2 cells were exposed to 600 l of viral supernatant col-
lected on day 4 of coinfection 1, containing approximately
108,000 PFU, eight of these formed large plaques (Fig. 2b).
Seven of these large plaques were picked, plaque purified three
times in HEp-2 cells, and designated rec-RSV isolates 1-1 to
1-7. As a control, several small plaques also were picked and
purified from the day 4 supernatants from coinfections 2 and 3:
these retained their small-plaque phenotype throughout the
plaque purification steps. Thus, the plaque morphology phe-
notypes of the parent mutant viruses and the rec-RSV were
preserved.
Following plaque purification, rec-RSV isolates 1-1 and 1-2
were used to infect both HEp-2 and Vero cell monolayers, and
plaque formation 6 days postinfection was compared to that of
wt rA2, G/HEK, and NS1/2 (Fig. 3). In HEp-2 cells, the
plaques of rec-RSV were approximately 45% larger than those
of wt rA2 and were easily differentiated from the pinpoint
plaques of G/HEK and NS1/2 (Fig. 3a to d). In Vero cells,
plaques formed by wt rA2 were slightly larger than those
formed by the purified rec-RSV, and plaques formed by wt rA2
or rec-RSV were larger than those of G/HEK and NS1/2
(Fig. 3e to h). It should be noted that, in Fig. 3, the viruses that
form larger plaques were infected at a lower MOI, and there-
fore, the differences in plaque number are not a reflection of
the plaquing efficiency of each of the viruses. Only rec-RSV 1-1
is shown in Fig. 3: rec-RSV 1-2 yielded the same results (data
not shown).
RT-PCR of plaque-purified viruses. Primer pairs A-B and
C-D (Fig. 1 and Table 1) were designed to span the NS1-NS2
genes and the SH-G genes, respectively, and thus differentiate
between the NS1/2 and G/HEK parental mutants based on
FIG. 2. Comparison of plaque size between G/HEK and rec-RSV present in the harvest from coinfection 1, one of six coinfections. Plaque
formation was detected by immunostaining as described in Materials and Methods after incubation under methylcellulose for 6 days. Note the
pinpoint plaques formed in the G/HEK infection (a) and the large-plaque variants observed in coinfection 1 (b; arrows) against the background
of pinpoint plaques. Large plaques were not observed in the other coinfections or in any single infection involving G/HEK, an example of which
is shown, or NS1/2 (data not shown).
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the size of the RT-PCR product. Primer pairs C–E-wt and
C–E-HEK (Fig. 1 and Table 1) were designed to differentiate
between viruses bearing the wt F gene and those bearing the F
gene containing the HEK mutation encoding the Gln-101-Pro
substitution.
RT-PCR of intracellular RNA from cells infected with wt
rA2/HEK (a version of wt rA2 containing the HEK and SITES
mutations but otherwise identical), wt rA2, and G/HEK with
primer pair A-B identified the presence of the NS1 and NS2
genes (1,327-bp product, Fig. 4a, lanes 1, 2, and 4) and the
absence of these genes from NS1/2 (273-bp product, Fig. 4a,
lane 3). RT-PCR of wt rA2/HEK, wt rA2, and NS1/2 with
primer pair C-D yielded in each case an 1,801-bp product (Fig.
4b, lanes 1, 2, and 3, respectively), consistent with the expected
presence of intact SH and G genes. In contrast, RT-PCR of
G/HEK with primer pair C-D yielded the expected 852-bp
product (Fig. 4b, lane 4), consistent with the known deletion.
RT-PCR with primer pair C–E-wt yielded the expected
1,954-bp product in the case of wt rA2 and NS1/2 (Fig. 4c,
lanes 2 and 3) but not wt rA2/HEK or G/HEK (Fig. 4c, lanes
1 and 4), confirming the specificity of this primer pair for the wt
F gene. Conversely, primer pair C–E-HEK yielded the ex-
pected products for wt rA2/HEK and G/HEK (Fig. 4d, lanes
1 and 4) and did not yield a product for wt rA2 or NS1/2 (Fig.
4d, lanes 2 and 3), confirming its specificity for the F gene
containing the Gln-101-Pro HEK mutation.
With their specificities confirmed, these primer sets were
used to analyze the supernatants resulting from the six coin-
fections. RT-PCR analysis with primer pairs A-B (spanning
NS1-NS2) and C-D (spanning SH-G) showed that both
NS1/2 and G/HEK were present in all supernatants har-
vested on day 4, confirming that both parental viruses had
replicated during the coinfections (data not shown). However,
potential recombined viral genomes were not evident from
analysis of the total supernatants.
Next, rec-RSV isolates 1-1 to 1-7 were analyzed by RT-PCR
to determine their genotype. RT-PCR with primer pair A-B
showed that the NS1 and NS2 genes were present in the seven
isolates of rec-RSV as evidenced by the 1,327-bp product (Fig.
4a, lanes 5 and 6, and data not shown). Surprisingly, analysis of
each of the seven isolates with primer pair C-D (spanning
SH-G) yielded a product of 500 bp (Fig. 4b, lanes 5 and 6,
and data not shown), which was smaller than either the
1,801-bp product derived from wt rA2 or the 852-bp product
derived from G/HEK. This suggested that the rec-RSV iso-
lates had sustained an additional deletion in the SH-F region.
RT-PCR with primer pairs C–E-wt and C–E-HEK showed that
the seven rec-RSV isolates each contained the HEK point
mutation of the G/HEK parent, as evidenced by the 1,954-bp
band present in Fig. 4d, lanes 5 and 6, and absent in Fig. 4c,
lanes 5 and 6. Thus, these analyses indicated that the seven
rec-RSV isolates were identical and contained the NS1, NS2,
and F genes of the G/HEK parent but contained a large
deletion in the SH-G region represented by primer pair C-D.
Sequence analysis of selected regions of the rec-RSV iso-
lates. As described above, RT-PCR of the rec-RSV isolates
with primer pair C-D (spanning SH-G) yielded an unexpect-
edly small product of 500 bp, suggesting that this region
contained a large deletion. Thus, the 500-bp RT-PCR prod-
ucts from each of the seven rec-RSV isolates were sequenced;
sequencing was performed directly on the uncloned material
and yielded the same sequence for each isolate. This sequence
FIG. 3. Photomicrographs of plaque formation in HEp-2 (a to d) and Vero (e to h) cells infected with rA2 (a and e), NS1/2 (b and f), G/HEK
(c and g), or plaque-purified rec-RSV 1-1 (d and h) derived from one of the large plaques identified from the coinfection 1 progeny. Infected cells
were incubated for 6 days under methylcellulose, and the plaques were visualized by immunostaining with a cocktail of anti-F monoclonal
antibodies.
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showed that rec-RSV contained a large deletion in the SH
gene, leaving only the first 12 nt of the gene including the gene
start signal (Fig. 5a). In addition, immediately downstream of
the truncated SH gene, rec-RSV contained an insertion of 91
nt of G, including the gene end signal. This in turn was fol-
lowed by the complete 52-nt G-F intergenic region, of which
only the downstream 38 nt were present in G/HEK (Fig. 5a).
In addition, the 12-nt segment from the SH gene and the 91-nt
segment from the G gene were separated by a CA dinucleotide
that could have been derived from either the SH or the G gene.
This resulted in a 105-nt chimeric SH:G gene that contained an
intact set of gene start and gene end transcription signals
flanked by intact intergenic regions, thus encoding a short
RNA; however, the RNA lacks a significant open reading
frame. To confirm these results, an independent primer pair
spanning the same general region (nt 4004 to 6094) was used to
generate an RT-PCR product for sequencing, which produced
the same results as described above.
The chimeric SH:G gene apparently represented a recom-
bination junction, with the upstream sequence derived from
G/HEK and the downstream sequence derived from NS1/2.
It was of interest to determine the extent of sequence related-
ness between the two templates in the region of recombina-
tion. This is shown in Fig. 5b, in which the top line is the
sequence of G/HEK in the vicinity of the upstream end of the
SH gene, the third line is that of NS1/2 in the vicinity of the
downstream end of the G gene, and the middle line is that of
rec-RSV. This comparison shows that, apart from the shared
CA dinucleotide, there is no significant sequence identity be-
tween the two sequence segments, indicating that a nonho-
mologous recombination event was involved.
The presence of the NS1 and NS2 genes and the upstream
end of the SH gene in rec-RSV suggested that all of the
sequence upstream of the junction was derived from the G/
HEK parent, while the downstream end of G and the adjoining
intergenic sequence were derived from NS1/2. However, as
described above, RT-PCR with the C–E-wt and C–E-HEK
primer pairs showed that the rec-RSV isolates also contained
the HEK mutation in the F gene (Fig. 4c and d). This sug-
gested that this region of the rec-RSV isolates also was derived
from G/HEK rather than NS1/2. This would mean that a
second recombination event had occurred, with its junction
located somewhere between the G-F intergenic region and the
second HEK mutation. To investigate this, RT-PCR was used
to amplify nt 4384 to 4894 of the rec-RSV isolates, which were
then sequenced. The sequence showed that the F gene con-
tained both of the HEK markers of the G/HEK parent and
did not otherwise contain any nucleotide changes. Confirma-
tion of the presence of the HEK markers supported the idea
that a second recombination had occurred. This event must
have occurred upstream of the HEK markers, within either the
downstream 38 nt of the G-F intergenic region or the upstream
198 nt of the F gene. The lack of nucleotide changes indicated
that this recombination event was homologous and precise.
The presence of the SITES markers in the L gene of the
G/HEK parent made it possible to determine the origin of
the L gene present in the rec-RSV isolates. The seven isolates
were subjected to RT-PCR to amplify part of the L gene that,
in G/HEK, contains three of the six SITES mutations. The
primers were specific for sequence not involved in the SITES
mutations (Materials and Methods) and thus would anneal to
either wt or SITES L sequence. The resulting RT-PCR prod-
ucts were sequenced, showing that each of the seven isolates
was identical and contained three SITES mutations, RsrII (nt
14083), BstEII (nt 14318), and SnaBI (nt 14477), unique to the
G/HEK mutant parent. The proposed recombination path-
way deduced from these results is shown in Fig. 5c.
Growth of rec-RSV in HEp-2 and Vero cells. The growth
kinetics of rec-RSV 1-1 and 1-2 in HEp-2 and Vero cells were
compared to those of the parental and wt viruses. Triplicate
FIG. 4. RT-PCR analysis of genomic RNA of parental viruses and
rec-RSV from total intracellular infected-cell RNA. Primer pairs A-B
(a), C-D (b), C–E-wt (c), and C–E-HEK (d) (Table 1 and Fig. 1) were
used to identify gene deletions and the presence or absence of HEK
point mutations in rA2/HEK (lane 1), wt rA2 (lane 2), NS1/2 (lane
3), G/HEK (lane 4), plaque-purified rec-RSV 1-1 (lane 5), and rec-
RSV 1-2 (lane 6). Note that rA2/HEK and wt rA2 are two versions of
wt rRSV that differ only by the presence of the HEK and SITES
mutations in the former. M, DNA ladder; -ve (lane 7), a negative
control lacking template. Primer pair A-B detects the presence or
absence of NS1 and NS2 based on product size. Primer pair C-D
detects the presence or absence of the G gene based on product size.
Primer pairs C–E-wt and C–E-HEK also detect the presence of the G
gene by product size and, in addition, are specific to wt and HEK
sequence, respectively, in the F gene.
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cultures of both cell lines were infected with either rec-RSV
1-1 or 1-2 or with wt rA2, G/HEK, or NS1/2 at an MOI of
0.01. Viral supernatants were harvested daily for 5 days, and
the resulting viral titers were determined (Fig. 6).
In both HEp-2 and Vero cells, the two rec-RSVs displayed
the same growth patterns. In HEp-2 cells, the titer of wt rA2
was significantly higher than that of rec-RSV from days 2 to 4,
but by day 5 the two viruses were similar (Fig. 6a). In contrast,
both the parental NS1/2 and G/HEK viruses grew more
slowly and to approximately 1,000-fold-lower final titers than
did wt rA2 and the rec-RSVs. In Vero cells, the growth kinetics
of rA2 and the rec-RSVs were very similar (Fig. 6b). The
kinetics of G/HEK production in Vero cells was similar to
that of the rec-RSVs and rA2 up to day 4, but thereafter the
titer appeared to be significantly higher than that for the other
viruses (Fig. 6b). This likely reflects the extensive cytopathol-
ogy and reduction of viable cells observed for rA2 and rec-RSV
infection by days 4 to 5 rather than a growth advantage for
FIG. 5. Structure of rec-RSV. (a) Gene maps of wt rA2 and rec-RSV. The sequence of the chimeric SH:G gene resulting from the intracellular
recombination event is shown in the box: italicized nucleotides (total of 12) were derived from the SH gene, nucleotides in regular text (total of
91) were derived from the G gene, and the intervening CA dinucleotide in boldface is the recombination junction, is present in both genes, and
could be derived from either. (b) Alignment of the sequences on either side of the recombination junction in the SH:G gene. The top sequence
is that of the parental G/HEK virus, beginning at nt 4222 and showing the upstream end of the SH gene with the CA junctional dinucleotide in
boldface; the bottom sequence is that of the parental NS1/2 virus, beginning at nt 5495 and showing the downstream end of the G gene with the
CA junctional dinucleotide in boldface; and the middle sequence is that of rec-RSV. This shows that the CA dinucleotide is one of the few scattered
points of sequence identity in this region between the two parental templates. (c) Gene maps of the parental G/HEK and NS1/2 viruses showing
the deduced path taken by the polymerase in jumping from the G/HEK genome to that of NS1/2 and back again (see the text). The upstream
recombination junction was identified by the sequence analysis in panel a; the position of the downstream junction is unknown but, given the
presence of a wt-like G-F junction and HEK markers in rec-RSV, presumably occurred at some point within the downstream 38 nt of the intergenic
region preceding the F gene or within the F gene upstream of the first HEK marker (dotted lines) and occurred without any sequence insertion
or deletion.
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G/HEK. NS1/2 grew less efficiently than the other viruses in
Vero cells, reaching final titers 100-fold less than those of
rA2 (Fig. 6b).
Viral RNA expression by rec-RSV. Total cellular RNA was
extracted from Vero cells that had been infected by wt rA2,
G/HEK, NS1/2, rec-RSV 1-1, or rec-RSV 1-2 or had been
left uninfected. Northern blot hybridization was performed
using dsDNA probes specific for the RSV N, P, SH, and G
genes. All viruses including the rec-RSV expressed P and N
mRNA, as expected (Fig. 7a and b). Monocistronic SH mRNA
was expressed by wt rA2, NS1/2, and G/HEK, as expected,
but not by the rec-RSV (Fig. 7c, lanes 1, 2, and 3 versus lanes
4 and 5). Full-length G mRNA was expressed by wt rA2 and
NS1/2 but not by either G/HEK, as expected, or rec-RSV
(Fig. 7d, lanes 1 and 2 versus lanes 3, 4, and 5). A small mRNA
of a size appropriate to represent the chimeric SH:G gene was
detected for rec-RSV by using the G-specific probe (Fig. 7d,
lanes 4 and 5). The failure of the SH probe to detect this
mRNA was expected, since it contains only 14 nt related to the
SH gene (Fig. 5c). In addition, the RNA from rec-RSV con-
tained a small amount of an mRNA that was marginally larger
than full-length G mRNA and was of the appropriate size to be
a readthrough of the M and novel SH:G genes (Fig. 7d, lanes
4 and 5).
Protein synthesis by rec-RSV. Further confirmation of the
absence of functional SH and G genes from rec-RSV was
provided by Western blot analysis. A portion of the cell pellets
used to extract total RNA for Northern blot analysis was used
for Western blot analysis. Expression of viral proteins was
determined by Western blot analysis of total cellular proteins
from the infected cells by using polyclonal antisera directed
against either purified RSV (Fig. 8b) or peptides derived from
the SH protein (Fig. 8c) or the G protein (Fig. 8a). Cells
infected by any of the viruses expressed the N, P, M, and M2-1
proteins, as expected (Fig. 8b). Both wt rA2 and NS1/2 ex-
pressed both G and SH (Fig. 8a and c, lanes 1 and 2). As
expected, the G/HEK virus-infected cells did not contain G
(Fig. 8a, lane 3) but retained SH expression (Fig. 8c, lane 3).
However, neither of the rec-RSV isolates directed the expres-
sion of G or SH (Fig. 8a and c, lanes 4 and 5), consistent with
the absence of either functional gene in the recombined vi-
ruses.
DISCUSSION
Although recombination between the genomes of positive-
sense RNA viruses is commonplace, the ability of mono-
negaviruses to undergo genetic recombination had not been
previously described. Therefore, we designed experimental
conditions to facilitate the detection of possible recombination
events. To do this, we performed coinfection with two mutant
RSVs that replicate inefficiently and form small plaques in
HEp-2 cells due to deletion of the NS1 and NS2 genes
(NS1/2) or the G gene (G/HEK). The NS1/2 and G gene
deletions are separated in the RSV genome by more than 3,500
nt, providing the possibility that recombination might occur
within this region and yield a virus with a complete set of genes
that would grow efficiently and be readily isolated from the
background of debilitated parental mutant viruses. Further-
more, the fact that the NS1, NS2, SH, and G genes are not
essential for RSV replication in vitro meant that imprecise
recombination that might occur would be tolerated within
these genes. The fact that each of two parents replicated poorly
in HEp-2 cells facilitated the identification of a virus that
replicated efficiently since it had the potential to outgrow ei-
ther parent and be detectable in their presence. Indeed, this
strategy resulted in the identification of a rec-RSV. Unexpect-
edly, however, while this virus did exhibit a growth advantage
over its parents, it was not due to the reacquisition of a deleted
gene through recombination. Also, the recovered rec-RSV ap-
peared to be the product of two recombination events, rather
than one.
One of six coinfections with G/HEK and NS1/2 yielded
rec-RSV with a growth advantage and the ability to form large
plaques compared to the two parental deletion viruses. Seven
isolates recovered from this one coinfection appeared to be
FIG. 6. Growth kinetics of plaque-purified rec-RSV isolates 1-1 and 1-2 compared to wt rA2, NS1/2, and G/HEK. Triplicate cultures of
HEp-2 (a) or Vero (b) cells were infected at an MOI of 0.01 PFU/cell. Supernatants were harvested daily and analyzed by plaque assay on Vero
cells. Plaques were visualized by immunostaining with RSV F-specific antibodies. Mean titers (log10 PFU per milliliter) are shown with twice the
standard error on either side of the mean.
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identical, suggesting that all of the rec-RSVs from this exper-
iment arose from a single recombined genome. The structure
of the rec-RSV was investigated by identifying genetic mark-
ers, specifically the presence or absence of the NS1 and NS2 or
G genes as well as the HEK and SITES markers in the F and
L genes, respectively, of the G/HEK parent. This, together
with nucleotide sequence analysis, provided evidence that most
of the genome of the rec-RSV was derived from the G/HEK
parent and that two recombination events were involved.
One recombination junction was identified by the finding
that the first 12 nt of the SH gene of rec-RSV were fused to the
last 91 nt of the G gene, the latter of which could have come
only from the NS1/2 parent. These two segments were sepa-
rated by a CA dinucleotide that was represented in both the
SH and G genes, which otherwise did not exhibit significant
sequence relatedness, and thus might have been derived from
either gene. It seems reasonable to suggest that, while base
pairing evidently was not involved in aligning the two templates
for recombination, this “homologous” dinucleotide probably
helped guide the nascent strand to the new template. Thus, this
recombination event fits the general category of “nonhomolo-
gous” (11), with the caveat that base pairing might have been
required for reinitiation of polymerization. It also might be
that the two templates were held in juxtaposition by base
pairing elsewhere along the two strands, even if base pairing
was not involved in the vicinity of the recombination.
The second recombination junction occurred within the last
38 nt of the G-F junction or the first 198 nt of the F gene. This
was deduced from the finding that the rec-RSV contained (i)
the complete 52-nt G-F intergenic region of wt RSV, which
was present in its entirety in the NS1/2 parent whereas only
the downstream 38 nt were present in G/HEK, and (ii) both
HEK markers from G/HEK. However, the exact junction
point within this region could not be deduced because there
were no sequence abnormalities. Thus, this recombination step
appeared to be homologous and precise. Recombination of
this type has not been described previously for a negative-
strand RNA virus and would be difficult to detect without the
use of multiple markers such as those used in the present study.
It seems likely that recombination took place during the
synthesis of antigenomic RNA from genomic templates, since
the latter are much more abundant in the infected cell, a factor
that would increase the efficiency and probability of the event.
If so, then the likely recombination pathway was that (i) syn-
thesis began in the leader region of the G/HEK genome and
FIG. 7. Northern blot hybridization of total intracellular RNA iso-
lated 24 h postinfection from Vero cells that were infected with either
wt rA2 (lane 1), NS1/2 (lane 2), G/HEK (lane 3), plaque-purified
rec-RSV 1-1 (lane 4), or plaque-purified rec-RSV 1-2 (lane 5) or were
mock infected (lane 6). The RNAs were subjected to electrophoresis
on formaldehyde gels, transferred to nitrocellulose, and hybridized to
32P-labeled dsDNA probes for the P (a), N (b), SH (c), or G (d) gene.
The positions of monocistronic P, N, SH, and G and the putative SH:G
mRNA are indicated: the faint upper band in lanes 4 and 5 is of the
appropriate size to be a readthrough of the M and SH:G genes.
FIG. 8. Western blot analysis of cell-associated proteins from Vero
cells that were infected with either wt rA2 (lane 1), NS1/2 (lane 2),
G/HEK (lane 3), plaque-purified rec-RSV 1-1 (lane 4), or plaque-
purified rec-RSV 1-2 (lane 5) or were mock infected (lane 6). Western
blot analysis was performed using antisera against a peptide represent-
ing amino acids 186 to 201 of the G protein (a), purified RSV (b), or
a peptide representing amino acids 53 to 64 of the SH protein (c). The
relevant cropped portions of blots are shown.
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proceeded to the SH gene; (ii) the polymerase and nascent
antigenome made a “nonhomologous,” imprecise jump from
the upstream region of the SH gene of G/HEK to the down-
stream region of the G gene of NS1/2, where copying re-
sumed across the end of the G gene, into the intergenic region
and, possibly, the F gene; and (iii) the polymerase and nascent
strand made a “homologous,” precise jump back to the G/
HEK strand and completed synthesis on that template (Fig.
5c).
For a recombination event to be considered as resulting in a
recombined, viable virus, it must be sustained in subsequent
generations and not lost through reversion to the principal
parental genome (23). We have demonstrated that rec-RSV
containing the SH:G chimeric gene and the other markers was
maintained during rounds of plaque purification and amplifi-
cation of the virus by serial passage in Vero cells. Northern and
Western analysis showed that rec-RSV replicated efficiently
despite the elimination of both G and SH proteins. Sequence
information showed that there was no reversion to the G/
HEK genome. Therefore, the formation of a chimeric SH:G
gene product is a stable recombination event and rec-RSV is a
viable recombined virus.
Interestingly, the chimeric SH:G gene identified in rec-RSV
is similar to that described by Karron et al. (10) for a cold-
passaged, attenuated RSV subgroup B mutant called cp-52.
The chimeric gene of both viruses has an SH gene start signal,
a G gene end signal, and proportionally more of the G gene
represented than the SH gene. The chimeric genes of the two
viruses are of similar length, 91 bases for cp-52 and 105 bases
for rec-RSV. The predicted chimeric mRNA is expressed in
each case and in each case lacks a significant open reading
frame. The recombination mechanism by which the deletion in
the cp-52 genome occurred is not known, but the recombina-
tion probably also occurred during antigenome synthesis (for
reasons of template abundance and probability, as discussed
above) and presumably involved nonhomologous jumping
from the upstream end of the SH of one template to the
downstream end of the G gene of either the same template or
a different template. The involvement of the SH-G region in
recombination in two studies raises the possibility that it might
be a “hot spot” for recombination, although this is only spec-
ulation at the present time. The rec-RSV contained intact NS1
and NS2 genes and lacked functional SH and G genes, and its
genome was 1,274 nt shorter than that of wt RSV and 165 or
450 nt shorter than that of G/HEK or NS1/2, respectively.
The growth advantage of rec-RSV compared to the NS1/2
parent is easy to understand, since the NS1 and NS2 proteins
are involved in counteracting the host interferon-mediated an-
tiviral state (17). The basis for the improved growth of rec-
RSV compared to G/HEK is less clear but presumably in-
volves the deletion of the SH gene and the shorter length of the
genome: both of these factors have been shown to yield in-
creases in growth or plaque size for RSV (1, 2, 19). It was
unexpected that rec-RSV grew similarly to wt rA2 in HEp-2
cells because rec-RSV lacks the G protein, whose absence had
previously been associated with reduced growth fitness in
HEp-2 cells (22). It may be that the additional loss of SH and
the reduction in the length of the genome played a role. It also
might be that the chimeric SH:G gene played a role; there is no
basis for this idea except for the odd coincidence mentioned
above that the efficiently growing cp-52 also contained a similar
chimeric gene. Thus, the acquisition of wt-like growth fitness
by rec-RSV remains unexplained but is not a central issue
here.
The recombination of two rRSV mutants to form a new
progeny genome was detected in only one of the six coinfec-
tions established in this study and appeared to involve only a
single recombined genome, despite the fact that the experi-
mental conditions had been optimized to facilitate the gener-
ation and identification of recombined variants. This suggests
that the formation of viable recombined RSV is rare in cell
culture and therefore likely to be even more uncommon in
nature, where the presence of large numbers of coinfected cells
is less likely. This is offered with the caveat that our conditions
would have detected recombinants that had a growth advan-
tage.
Our expectation had been that, under optimal conditions,
recombination would be detected more frequently, since large-
plaque formation by G/HEK should theoretically require
only the reacquisition of the G gene by a single crossover
within the 3,500 nt between the end of NS2 and the start of
G. Since we were able to observe only one recombination event
in six independent coinfections, it appears that the frequency
of recombination, whether homologous or nonhomologous, is
very low. However, the recent finding that recombination of
influenza virus (14) RNA segments appeared to occur fre-
quently indicates that this should be examined carefully for
mononegaviruses. We are further refining our present system
to examine RSV recombination more precisely.
Although the present study suggests that the rate of RSV
recombination is very low, this does not mean that recombi-
nation has played no role in mononegavirus evolution. For
example, the genomes of existing mononegaviruses share a
common set of genes, N-P-M-(G/H/HN)-L, but also variably
contain additional interspersed genes such as NS1, NS2, SH,
and M2. Assuming that present-day mononegaviruses arose
from a common ancestor, recombination might have played a
role in the insertion or deletion of genes, although other mech-
anisms also are possible. A second example involves the dif-
ferences in gene order between two pneumoviruses, namely,
RSV (NS1-NS2-N-P-M-SH-G-F-M2-L) and human metapneu-
movirus (N-P-M-F-M2-SH-G-L). These differences include
the absence of the NS1 and NS2 genes in human metapneu-
movirus and a difference in the order of the F-M2 gene pair
relative to the SH-G gene pair. This latter difference illustrates
a likely rearrangement in gene order, presumably mediated by
recombination, involved in the divergence of these two pneu-
moviruses.
A third example comes from sequence analysis of RSV iso-
lates, in which a segment of the SH gene of several isolates of
one genetic lineage appeared to be derived from a second
lineage (27). This suggested that the polymerase had jumped
over, copied part of the SH gene, and jumped back. Here it is
of interest that, once again, the SH gene was involved. These
precedents not withstanding, the apparent low frequency of
recombination for RSV suggests that it does not make an
important contribution to the swarm of mutants that is char-
acteristic of a population of mononegavirus and may not make
a significant contribution to the maintenance and evolution of
genetically diverse strains that are characteristic of RSV.
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With regard to the development of RSV vaccine candidates
containing defined, circumscribed attenuating mutations, even
if recombination were frequent, it should not pose a concern
for vaccine safety, since a cross between an attenuated strain
and a wt strain would yield intermediately attenuated progeny
that should not pose a threat in a world already full of wt RSV.
Also, human and animal RSVs do not appear to have highly
pathogenic variants or biotypes that might otherwise provide
the possibility of the emergence of new virulent strains through
recombination. Given the apparent low rate of recombination
observed here, it is clear that recombination is not a concern
for vaccine stability and safety.
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